First Time Loading...

Amphastar Pharmaceuticals Inc
NASDAQ:AMPH

Watchlist Manager
Amphastar Pharmaceuticals Inc Logo
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Watchlist
Price: 41.11 USD 0.69% Market Closed
Updated: Apr 29, 2024
Section:
 

Relative Value

The Relative Value of one AMPH stock under the Base Case scenario is 72.69 USD. Compared to the current market price of 41.11 USD, Amphastar Pharmaceuticals Inc is Undervalued by 43%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AMPH Relative Value
Base Case
72.69 USD
Undervaluation 43%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.1
P/S
P/S
Price to Sales
3.1
vs History
42
vs Industry
38
Median 3Y
3.1
Median 5Y
2.9
Industry
2.4
Forward
2.6
More Details
14.4
P/E
P/E
Price to Earnings
14.4
vs History
95
vs Industry
32
Median 3Y
20.5
Median 5Y
20
Industry
22.9
Forward
10.7
More Details
10.8
P/OCF
P/OCF
Price to OCF
10.8
vs History
96
vs Industry
34
Median 3Y
13.4
Median 5Y
15.3
Industry
17.1
More Details
3
P/FCFE
P/FCFE
Price to FCFE
3
vs History
77
vs Industry
35
Median 3Y
13.8
Median 5Y
13.5
Industry
23.2
More Details
3.1
P/B
P/B
Price to Book Value
3.1
vs History
31
vs Industry
26
Median 3Y
3.1
Median 5Y
2.7
Industry
2.1
More Details
3.6
EV/S
EV/S
Enterprise Value to Sales
3.6
vs History
23
vs Industry
33
Median 3Y
3.2
Median 5Y
2.7
Industry
2.6
Forward
3.1
More Details
6.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
6.5
vs History
41
vs Industry
33
Median 3Y
6.3
Median 5Y
6.3
Industry
5.1
More Details
9.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
9.7
vs History
96
vs Industry
35
Median 3Y
12.7
Median 5Y
18.1
Industry
13.6
Forward
7.4
More Details
11.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
11.6
vs History
87
vs Industry
36
Median 3Y
17.3
Median 5Y
18.3
Industry
17
Forward
9.1
More Details
12.6
EV/OCF
EV/OCF
Enterprise Value to OCF
12.6
vs History
74
vs Industry
33
Median 3Y
13.6
Median 5Y
15.4
Industry
15.8
More Details
15.9
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
15.9
vs History
80
vs Industry
24
Median 3Y
18.3
Median 5Y
20
Industry
17.6
More Details
1.9
EV/IC
EV/IC
Enterprise Value to IC
1.9
vs History
57
vs Industry
39
Median 3Y
2.4
Median 5Y
2.1
Industry
1.9
More Details

Multiples Across Competitors

AMPH Competitors Multiples
Amphastar Pharmaceuticals Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
2B USD 3.1 14.4 9.7 11.6
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
696.4B USD 20.4 132.9 60.1 68.9
DK
Novo Nordisk A/S
CSE:NOVO B
4T DKK 17 47.2 34.6 37.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
JP
Taisho Pharmaceutical Holdings Co Ltd
TSE:4581
82T JPY 255.8 9 733.7 1 771.8 4 320.3
US
Johnson & Johnson
NYSE:JNJ
351.8B USD 4.3 8.7 11.6 15.3
US
Merck & Co Inc
NYSE:MRK
332.2B USD 5.5 910 45.2 88.2
UK
AstraZeneca PLC
LSE:AZN
185.8B GBP 5.1 39 140.5 225.3
CH
Novartis AG
SIX:NOVN
182.9B CHF 4.3 13.5 9.9 16.3
CH
Roche Holding AG
SIX:ROG
176.2B CHF 3 15.3 8.5 10

See Also

Summary
AMPH intrinsic value, competitors valuation, and company profile.
DCF Valuation
AMPH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AMPH stock valuation using valuation multiples.
Wall Street Estimates
AMPH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AMPH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 132,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.